Literature DB >> 19030334

Approach to febrile neutropenia in the general paediatric setting.

Lillian Sung1, Donna L Johnston.   

Abstract

Febrile neutropenia is common in children with cancer and can also occur outside of the oncology setting. The present article provides an overview of febrile neutropenia from the general paediatric perspective.In cancer patients, the principles of febrile neutropenia management have remained relatively constant. For neutropenic children with cancer, empirical antibiotics should be initiated at the onset of fever. There is insufficient evidence at this point to recommend exclusively outpatient management of the child with cancer-related febrile neutropenia.Far less is known about febrile neutropenia in the noncancer setting. The approach to this condition should be influenced by the underlying condition and its associated risk of invasive infection and serious outcome in the absence of hospitalization and empirical antibiotic therapy.

Entities:  

Keywords:  Cancer; Children; Empirical antibiotics; Febrile neutropenia

Year:  2007        PMID: 19030334      PMCID: PMC2528657          DOI: 10.1093/pch/12.1.19

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  19 in total

1.  Clinical significance of newly documented neutropenia in febrile young infants evaluated for sepsis.

Authors:  W A Bonadio; D S Smith; S Mathews; A Rock
Journal:  Pediatr Infect Dis J       Date:  1991-05       Impact factor: 2.129

2.  The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation.

Authors:  J A Talcott; R Finberg; R J Mayer; L Goldman
Journal:  Arch Intern Med       Date:  1988-12

3.  Management of the febrile, otherwise healthy child with neutropenia.

Authors:  A J Alario
Journal:  Pediatr Infect Dis J       Date:  1994-02       Impact factor: 2.129

4.  Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

Authors:  W V Kern; A Cometta; R De Bock; J Langenaeken; M Paesmans; H Gaya
Journal:  N Engl J Med       Date:  1999-07-29       Impact factor: 91.245

5.  Early discharge of low-risk febrile neutropenic children and adolescents with cancer.

Authors:  V M Aquino; I Tkaczewski; G R Buchanan
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

6.  "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia.

Authors:  R J Klaassen; T R Goodman; B Pham; J J Doyle
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

7.  Clinical characteristics of children with fever and transient neutropenia who experience serious bacterial infections.

Authors:  W A Bonadio; E Stremski; K Shallow
Journal:  Pediatr Emerg Care       Date:  1989-09       Impact factor: 1.454

Review 8.  Approach to management of fever and infection in patients with primary bone marrow failure and hemoglobinopathies.

Authors:  M Weinberger
Journal:  Hematol Oncol Clin North Am       Date:  1993-08       Impact factor: 3.722

9.  Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.

Authors:  J A Talcott; R D Siegel; R Finberg; L Goldman
Journal:  J Clin Oncol       Date:  1992-02       Impact factor: 44.544

10.  Risk of infectious complications in well-appearing children with transient neutropenia.

Authors:  A J Alario; J S O'Shea
Journal:  Am J Dis Child       Date:  1989-08
View more
  4 in total

1.  Clinical Profile and Short Term Outcome of Children with Neutropenia.

Authors:  Akanksha Mahajan; Virendra Kumar; Sangeeta Pahuja Sindhwani; Viswas Chhapola
Journal:  Indian J Pediatr       Date:  2019-07-06       Impact factor: 1.967

2.  Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department.

Authors:  C Pascual; V Trenchs; S Hernández-Bou; A Català; A F Valls; C Luaces
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-18       Impact factor: 3.267

3.  Comparison of the etiologic, microbiologic, clinical and outcome characteristics of febrile vs. non-febrile neutropenia in hospitalized immunocompetent children.

Authors:  Eugene Leibovitz; Joseph Kapelushnik; Sabrin Alsanaa; Dov Tschernin; Ruslan Sergienko; Ron Leibovitz; Julia Mazar; Yariv Fruchtman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-27       Impact factor: 3.267

4.  Infectious events prior to chemotherapy initiation in children with acute myeloid leukemia.

Authors:  Carol Portwine; David Mitchell; Donna Johnston; Biljana Gillmeister; Marie-Chantal Ethier; Rochelle Yanofsky; David Dix; Sonia Cellot; Victor Lewis; Victoria Price; Mariana Silva; Shayna Zelcer; Lynette Bowes; Bruno Michon; Kent Stobart; Josee Brossard; Joseph Beyene; Lillian Sung
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.